BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michelsen S, Nachi S, Van Dyck W, Simoens S, Huys I. Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies. Front Pharmacol 2020;11:594446. [PMID: 33363468 DOI: 10.3389/fphar.2020.594446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pochopień M, Qiu T, Aballea S, Clay E, Toumi M. Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies. Expert Rev Pharmacoecon Outcomes Res 2021;:1-14. [PMID: 34407704 DOI: 10.1080/14737167.2021.1969229] [Reference Citation Analysis]
2 Jørgensen J, Kefalas P. The use of innovative payment mechanisms for gene therapies in Europe and the USA. Regen Med 2021;16:405-22. [PMID: 33847163 DOI: 10.2217/rme-2020-0169] [Reference Citation Analysis]